PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 12:05 AM ET

Sponsor Check › Person

Richard Upton

Related person on Form D filings · address states as listed: MA, AZ, NH, PA · listed Jul 1, 2009 → May 26, 2026

8issuers
58Form D filings
2009–2026years listed

Data last updated: Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 23, 2026, 11:55 PM ET · SEC enforcement last checked: not yet

Privacy: business-related public information only. Residential addresses are never shown; only the state from the filing.

Key records

The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.

1. Lawsuits

None found in sources searched.

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30) — federal district + bankruptcy courts; live RECAP re-check pending. State courts: not yet searched. PACER: not searched. · Last checked Oct 23, 2026, 11:55 PM ET.

State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.

Not yet searched.

Search queued. Results are added automatically; check back later or follow this page to be notified.

3. Bankruptcies

None found in sources searched.

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Last checked Oct 23, 2026, 11:55 PM ET.

State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons are made for sponsors and sponsor groups, not individual people.

5. Money to insiders and sales commissions

5 of 40 offerings report sales commissions totalling $1,732,137; 2 report finder's fees totalling $319,200; 1 reports proceeds to related persons totalling $450,000. (includes amounts the issuer reported as estimates)

SourceOffering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell it
EDGAR ↗May 26, 2026 D/A
File 021-564918
$0$0$0None listed on this filing
EDGAR ↗Mar 30, 2026 D
File 021-578166
$0$0$0None listed on this filing
EDGAR ↗Nov 21, 2025 D/A
File 021-523914
$0$66,450$450,000 (est.)U.S. Boston Capital Corporation BrokerCheck CRD 5251 ↗
EDGAR ↗Jan 29, 2025 D
File 021-536716
$0$0$0None listed on this filing
EDGAR ↗Jan 14, 2025 D
File 021-535097
$127,925$0$0Arcadia Securities, LLC BrokerCheck CRD 44656 ↗
EDGAR ↗Jan 8, 2025 D/A
File 021-497946
$0$252,750 (est.)$0 (est.)Brookline Capital Markets BrokerCheck CRD 44656 ↗
via Arcadia Securities, LLC (CRD 44656 ↗)
EDGAR ↗Apr 30, 2024 D
File 021-511918
$212,212$0$0Arcadia Securities, LLC BrokerCheck CRD 44656 ↗
EDGAR ↗Apr 24, 2024 D/A
File 021-458336
$0$0$0None listed on this filing
EDGAR ↗Dec 17, 2021 D/A
File 021-418399
$0$0$0None listed on this filing
EDGAR ↗Jun 17, 2021 D
File 021-403333
$0$0$0 (est.)None listed on this filing
EDGAR ↗Apr 7, 2021 D
File 021-394882
$0$0$0None listed on this filing
EDGAR ↗Sep 25, 2020 D/A
File 021-351149
$37,000$0$0Alere Financial Partners BrokerCheck CRD 109761 ↗
EDGAR ↗Sep 2, 2020 D
File 021-374667
$0$0$0 (est.)None listed on this filing
EDGAR ↗Jul 8, 2020 D
File 021-370440
$0$0$0None listed on this filing
EDGAR ↗Jul 3, 2019 D
File 021-343432
$0$0$0None listed on this filing
EDGAR ↗Apr 11, 2019 D
File 021-337003
$0$0$0None listed on this filing
EDGAR ↗Mar 14, 2019 D/A
File 021-316859
$855,000 (est.)$0$0Dalmore Group, LLC BrokerCheck CRD 136352 ↗
EDGAR ↗Apr 25, 2018 D/A
File 021-302818
$500,000 (est.)$0$0Dalmore Group, LLC BrokerCheck CRD 136352 ↗
EDGAR ↗Jan 17, 2018 D
File 021-303428
$0$0$0None listed on this filing
EDGAR ↗Dec 6, 2017 D/A
File 021-295847
$0$0$0None listed on this filing
EDGAR ↗Nov 2, 2017 D/A
File 021-295130
$0$0$0None listed on this filing
EDGAR ↗Apr 14, 2017 D/A
File 021-277897
$0$0$0None listed on this filing
EDGAR ↗Feb 5, 2016 D
File 021-256860
$0$0$0None listed on this filing
EDGAR ↗Dec 24, 2015 D
File 021-253842
$0$0$0 (est.)
Certain proceeds will be used by the Company for general working capital, including payment of salaries to certain executive officers and/or directors who are listed as Related Persons herein.
None listed on this filing
EDGAR ↗Aug 4, 2015 D
File 021-245065
$0$0$0None listed on this filing
EDGAR ↗Jun 15, 2015 D
File 021-241792
$0$0$0None listed on this filing
EDGAR ↗Dec 30, 2014 D/A
File 021-228137
$0$0$0None listed on this filing
EDGAR ↗Jun 19, 2014 D
File 021-219492
$0$0$0None listed on this filing
EDGAR ↗Jun 11, 2014 D/A
File 021-208619
$0$0$0None listed on this filing
EDGAR ↗Jan 13, 2014 D
File 021-209926
$0$0$0
Certain proceeds will be used by the Company for general working capital, including the payment of salaries to certain executive officers and/or directors who are listed as Related Persons herein.
None listed on this filing
EDGAR ↗May 20, 2013 D
File 021-196745
$0$0$0
Certain proceeds will be used by the Company for general working capital, including the payment of salaries to certain executive officers and/or directors who are listed as Related Persons herein.
None listed on this filing
EDGAR ↗Mar 26, 2013 D
File 021-193926
$0$0$0None listed on this filing
EDGAR ↗Dec 14, 2012 D
File 021-188411
$0$0$0None listed on this filing
EDGAR ↗Jun 6, 2012 D
File 021-179360
$0 (est.)$0 (est.)$0 (est.)None listed on this filing
EDGAR ↗Mar 27, 2012 D
File 021-175689
$0$0$0None listed on this filing
EDGAR ↗Oct 7, 2011 D
File 021-166905
$0$0$0None listed on this filing
EDGAR ↗Apr 13, 2011 D
File 021-158316
$0$0$0None listed on this filing
EDGAR ↗Aug 16, 2010 D
File 021-146444
$0$0$0None listed on this filing
EDGAR ↗Aug 5, 2010 D
File 021-146002
$0$0$0 (est.)
A portion of the use of proceeds may be used to pay officer salaries in the ordinary course of business.
None listed on this filing
EDGAR ↗Nov 12, 2009 D
File 021-132389
$0$0$0None listed on this filing

As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Appears on these filings

SourceIssuerRoleFiledFormOfferingSoldInvestorsMin. investment
EDGAR ↗Neela Therapeutics, Inc.DirectorMay 26, 2026D/A$21,510,000
similar: $829,831–$9,999,998
$13,821,64321
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Longevity Health Holdings, Inc.DirectorMar 30, 2026D$200,000
similar: $829,831–$9,999,998
$200,0001
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Neela Therapeutics, Inc.DirectorNov 24, 2025D$13,510,000
similar: $829,831–$9,999,998
$12,010,00017
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Anuncia Medical, Inc.DirectorNov 21, 2025D/A$16,442,486
similar: $2,000,000–$19,999,994
$13,908,00887
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Longevity Health Holdings, Inc.DirectorJan 29, 2025D$1,075,463
similar: $829,831–$9,999,998
$975,4631
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Longevity Health Holdings, Inc.DirectorJan 14, 2025D$3,709,996
similar: $829,831–$9,999,998
$1,854,99814
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Alcyone Therapeutics, Inc.DirectorJan 8, 2025D/A$31,608,219
similar: $829,831–$9,999,998
$19,032,81225
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Anuncia Medical, Inc.DirectorNov 18, 2024D/A$13,422,486
similar: $2,000,000–$19,999,994
$12,189,29869
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Anuncia Medical, Inc.DirectorSep 12, 2024D$13,422,486
similar: $2,000,000–$19,999,994
$10,751,86166
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Longevity Health Holdings, Inc.DirectorApr 30, 2024D$3,000,000
similar: $829,831–$9,999,998
$3,000,00019
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Anuncia Medical, Inc.DirectorApr 24, 2024D/A$4,000,000
similar: $2,000,000–$19,999,994
$3,409,30628
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Alcyone Therapeutics, Inc.DirectorNov 22, 2023D$31,608,219
similar: $829,831–$9,999,998
$17,257,81422
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Anuncia Medical, Inc.DirectorOct 19, 2023D/A$3,500,000
similar: $2,000,000–$19,999,994
$2,614,30622
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Anuncia Medical, Inc.DirectorMar 29, 2023D/A$2,500,000
similar: $2,000,000–$19,999,994
$1,825,60714
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Anuncia Medical, Inc.DirectorSep 8, 2022D$1,500,000
similar: $2,000,000–$19,999,994
$998,6078
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Anuncia Medical, Inc.DirectorDec 17, 2021D/A$1,500,000
similar: $2,000,000–$19,999,994
$427,5007
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Anuncia Medical, Inc.DirectorOct 25, 2021D$700,000
similar: $2,000,000–$19,999,994
$127,5002
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Alcyone Therapeutics, Inc.DirectorJun 17, 2021D$37,103,349
similar: $829,831–$9,999,998
$37,103,34931
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Medicinal Genomics CorpDirectorApr 7, 2021D$2,684,362
similar: $2,000,000–$19,999,994
$2,684,36265
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Carmell Therapeutics CorpDirectorSep 25, 2020D/A$3,500,000
similar: $2,000,000–$19,999,994
$2,384,32437
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Alcyone Therapeutics, Inc.DirectorSep 2, 2020D$19,458,809
similar: $829,831–$9,999,998
$17,550,17428
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Carmell Therapeutics CorpDirectorJul 8, 2020D$50,000
similar: $2,000,000–$19,999,994
$50,0001
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Carmell Therapeutics CorpDirectorOct 16, 2019D$2,300,000
similar: $2,000,000–$19,999,994
$80,0002
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Alcyone Therapeutics, Inc.DirectorJul 3, 2019D$3,000,000
similar: $829,831–$9,999,998
$2,208,33017
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Alcyone Therapeutics, Inc.DirectorApr 11, 2019D$1,650,000
similar: $829,831–$9,999,998
$1,650,00017
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Carmell Therapeutics CorpDirectorMar 14, 2019D/A$7,500,000
similar: $2,000,000–$19,999,994
$5,184,53544
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Carmell Therapeutics CorpDirectorJul 13, 2018D$4,500,000
similar: $2,000,000–$19,999,994
$1,150,0008
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Carmell Therapeutics CorpDirectorApr 25, 2018D/A$6,000,000
similar: $2,000,000–$19,999,994
$439,1606
similar: 2–16
$25,000
similar: $10,000–$50,000
EDGAR ↗Alcyone Therapeutics, Inc.DirectorJan 17, 2018D$5,140,609
similar: $829,831–$9,999,998
$5,140,60922
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Carmell Therapeutics CorpDirectorJan 10, 2018D$6,000,000
similar: $2,000,000–$19,999,994
$364,1605
similar: 2–16
$25,000
similar: $10,000–$50,000
EDGAR ↗Carmell Therapeutics CorpDirectorDec 6, 2017D/A$2,000,000
similar: $2,000,000–$19,999,994
$1,967,00925
similar: 2–16
$3,741
similar: $10,000–$50,000
EDGAR ↗Medicinal Genomics CorpDirectorNov 2, 2017D/A$5,003,160
similar: $2,000,000–$19,999,994
$5,003,16043
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Carmell Therapeutics CorpDirectorOct 3, 2017D$1,500,000
similar: $2,000,000–$19,999,994
$398,2354
similar: 2–16
$25,000
similar: $10,000–$50,000
EDGAR ↗Medicinal Genomics CorpDirectorSep 21, 2017D$5,000,000
similar: $2,000,000–$19,999,994
$3,795,02716
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Carmell Therapeutics CorpDirectorApr 14, 2017D/A$2,000,000
similar: $2,000,000–$19,999,994
$1,055,57525
similar: 2–16
$10,000
similar: $10,000–$50,000
EDGAR ↗Carmell Therapeutics CorpDirectorJan 9, 2017D$1,500,000
similar: $2,000,000–$19,999,994
$767,47417
similar: 2–16
$10,000
similar: $10,000–$50,000
EDGAR ↗Carmell Therapeutics CorpDirectorFeb 5, 2016D$1,000,000
similar: $2,000,000–$19,999,994
$774,8538
similar: 2–16
$5,683
similar: $10,000–$50,000
EDGAR ↗Alcyone Therapeutics, Inc.DirectorDec 24, 2015D$3,720,388
similar: $829,831–$9,999,998
$3,640,31920
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Carmell Therapeutics CorpDirectorAug 4, 2015D$300,000
similar: $2,000,000–$19,999,994
$137,2335
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Medicinal Genomics CorpDirectorJun 15, 2015DIndefinite
similar: $2,000,000–$19,999,994
$7,500,0003
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Carmell Therapeutics CorpDirectorDec 30, 2014D/A$556,172
similar: $2,000,000–$19,999,994
$556,17211
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Carmell Therapeutics CorpDirectorNov 12, 2014D$500,000
similar: $2,000,000–$19,999,994
$303,8186
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Medicinal Genomics CorpDirectorJun 19, 2014DIndefinite
similar: $2,000,000–$19,999,994
$6,272,59844
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Carmell Therapeutics CorpDirectorJun 11, 2014D/A$1,000,000
similar: $2,000,000–$19,999,994
$681,45611
similar: 2–16
$25,000
similar: $10,000–$50,000
EDGAR ↗Alcyone Therapeutics, Inc.DirectorJan 13, 2014D$4,000,000
similar: $829,831–$9,999,998
$4,000,00019
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Carmell Therapeutics CorpDirectorDec 23, 2013D$1,000,000
similar: $2,000,000–$19,999,994
$370,0005
similar: 2–16
$50,000
similar: $10,000–$50,000
EDGAR ↗Alcyone Therapeutics, Inc.DirectorMay 20, 2013D$1,000,004
similar: $829,831–$9,999,998
$1,000,00418
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Medicinal Genomics CorpDirectorMar 26, 2013DIndefinite
similar: $2,000,000–$19,999,994
$00
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Carmell Therapeutics CorpDirectorDec 14, 2012D$500,000
similar: $2,000,000–$19,999,994
$410,7978
similar: 2–16
$4,257
similar: $10,000–$50,000
EDGAR ↗CASTLEWOOD SURGICAL INCDirectorJun 6, 2012D$1,000,000
similar: $829,831–$9,999,998
$408,7639
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Alcyone Therapeutics, Inc.DirectorMar 27, 2012D$2,000,000
similar: $829,831–$9,999,998
$1,835,00714
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Medicinal Genomics CorpDirectorOct 7, 2011D$8,000,000
similar: $2,000,000–$19,999,994
$8,000,00067
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Carmell Therapeutics CorpDirectorApr 13, 2011D$2,970,000
similar: $2,000,000–$19,999,994
$2,389,2289
similar: 2–16
$25,000
similar: $10,000–$50,000
EDGAR ↗Medicinal Genomics CorpDirectorAug 16, 2010D$7,008,402
similar: $2,000,000–$19,999,994
$7,008,40249
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Eggrock, Inc.
group: Eggrock
DirectorAug 5, 2010D$2,500,000
similar: $1,000,000–$7,247,539
$500,0002
similar: 2–13
$100,000
similar: $10,000–$60,000
EDGAR ↗Eggrock, Inc.
group: Eggrock
DirectorNov 12, 2009D$750,000
similar: $1,000,000–$7,247,539
$750,0001
similar: 2–13
No minimum reported
similar: $10,000–$60,000
EDGAR ↗Eggrock, Inc.
group: Eggrock
DirectorSep 22, 2009D$750,000
similar: $1,000,000–$7,247,539
$750,0002
similar: 2–13
No minimum reported
similar: $10,000–$60,000
EDGAR ↗Eggrock, Inc.
group: Eggrock
DirectorJul 1, 2009D$1,999,999
similar: $1,000,000–$7,247,539
$1,999,9991
similar: 2–13
No minimum reported
similar: $10,000–$60,000

Every row is a Form D or D/A on which the issuer listed this name as a related person. Related-person names are matched on first + last name and the address state on the filing; records that share a name but could not be tied together by a second identifier are listed separately below.

"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); Biotechnology / 506(b) (3,253 filings); Manufacturing / 506(b) (1,339 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other listings under the same name

Not linked to this profile — a second identifier (same issuer, same sponsor group) was not found. Could be the same person or a different one.

  • Richard Upton — address state VA, 1 issuer, Feb 3, 2010 → Feb 3, 2010

Connections as of Oct 23, 2026, 5:45 PM ET

Listed alongside — 40 names on the same filings (0 management entities, 40 people)

People and management entities the issuers listed as related persons on the same Form D filings as Richard Upton. Source: the EDGAR rows in the table above. Showing the 40 with the most shared filings.

  • David Donabedian — 22 shared filings (3 issuers) · role as listed: Director · also listed on 22 other issuers
  • PJ Anand — 22 shared filings (3 issuers) · roles as listed: Executive Officer, Director · also listed on 1 other issuer
  • Stephen Oesterle — 18 shared filings (3 issuers) · role as listed: Director · also listed on 1 other issuer
  • James F. Jordan — 17 shared filings (1 issuer) · role as listed: Director · also listed on 1 other issuer
  • David W. Anderson — 12 shared filings (2 issuers) · role as listed: Director · also listed on 5 other issuers
  • Cameron Durrant — 11 shared filings (2 issuers) · role as listed: Director
  • Edgar D. Jannotta, Jr. — 11 shared filings (2 issuers) · role as listed: Director · also listed on 1 other issuer
  • Randolph Hubbell — 11 shared filings (1 issuer) · roles as listed: Executive Officer, Director
  • Donna Godward — 10 shared filings (1 issuer) · role as listed: Executive Officer
  • James Hart — 10 shared filings (1 issuer) · role as listed: Executive Officer · also listed on 1 other issuer
  • Stephanie Kladakis — 10 shared filings (1 issuer) · role as listed: Executive Officer
  • Stanton Rowe — 9 shared filings (1 issuer) · role as listed: Director
  • Elsa Abruzzo — 9 shared filings (1 issuer) · roles as listed: Executive Officer, Director
  • Edgar D Janotta — 9 shared filings (1 issuer) · role as listed: Director
  • William R. Newlin — 8 shared filings (1 issuer) · roles as listed: Director, Executive Officer · also listed on 5 other issuers
  • Richard T. McKernan — 8 shared filings (1 issuer) · role as listed: Director
  • Brendan L. McKernan — 8 shared filings (1 issuer) · roles as listed: Executive Officer, Director
  • Alan I. West — 8 shared filings (1 issuer) · roles as listed: Executive Officer, Director
  • Paul Kornblith — 8 shared filings (1 issuer) · roles as listed: Director, Executive Officer · also listed on 2 other issuers
  • Philip Chapman — 8 shared filings (1 issuer) · role as listed: Director
  • Patrick B. Costello — 6 shared filings (1 issuer) · role as listed: Executive Officer
  • Stephen M. McLean — 5 shared filings (1 issuer) · role as listed: Director
  • John J. Altorelli — 5 shared filings (1 issuer) · roles as listed: Executive Officer, Director
  • Ghassan Kassab — 4 shared filings (1 issuer) · role as listed: Director
  • Jeffrey L. Barrett — 4 shared filings (1 issuer) · roles as listed: Executive Officer, Director · also listed on 1 other issuer
  • William Seery — 4 shared filings (1 issuer) · role as listed: Executive Officer · also listed on 1 other issuer
  • Joshua Tolkoff — 4 shared filings (1 issuer) · role as listed: Director · also listed on 1 other issuer
  • Wendy DiCicco — 4 shared filings (1 issuer) · role as listed: Director · also listed on 4 other issuers
  • R. Brian McKernan — 4 shared filings (1 issuer) · roles as listed: Executive Officer, Director
  • Emery G. Olcott — 4 shared filings (1 issuer) · role as listed: Director
  • Gilles Spenlehauer — 4 shared filings (1 issuer) · role as listed: Director
  • Kathryn Gregory — 4 shared filings (1 issuer) · role as listed: Director
  • Patrick Sturgeon — 4 shared filings (1 issuer) · role as listed: Director
  • Rajiv S. Shukla — 4 shared filings (1 issuer) · roles as listed: Executive Officer, Director
  • Todd Warden — 4 shared filings (1 issuer) · role as listed: Director
  • Norbert Riedel — 4 shared filings (2 issuers) · role as listed: Director
  • Mark H. DeBlois — 3 shared filings (1 issuer) · role as listed: Director · also listed on 8 other issuers
  • Kevin J. McKernan — 3 shared filings (1 issuer) · role as listed: Executive Officer
  • Scott Frisch — 3 shared filings (1 issuer) · role as listed: Director
  • Bryan Cassaday — 3 shared filings (1 issuer) · role as listed: Executive Officer

Other offering types (Regulation A and Regulation Crowdfunding)

None found in sources searched.

Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.

Export this report as PDF (members · included free during the launch period)

Change history

No corrections have been requested for this page.

Facts from public records only, each linked to its source. No ratings, no opinions. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Richard Upton appears on a new Form D, or when a court case or SEC action is matched to them. See plans →